Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
Anti-Cancer Drugs|October 1, 2004
Is inhibition of cancer angiogenesis and growth by paclitaxel schedule dependent?Derick Lau, Linlang Guo, David Gandara, et al.Clinical Lung Cancer|February 20, 2008
Chemotherapy for brain metastases in small-cell lung cancerGigi Chen, Minh Huynh, Allan Chen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2011
A practical guide of the Southwest Oncology Group to measure malignant pleural mesothelioma tumors by RECIST and modified RECIST criteriaAnne S Tsao, Linda Garland, Mary Redman, et al.Critical Reviews in Oncology/Hematology|January 17, 2025
Role of the International Society of Liquid Biopsy (ISLB) in establishing quality control frameworks for clinical integrationNicola Fusco, Eloisa Jantus-Lewintre, Maria Jose Serrano, et al.American Journal of Clinical Oncology|June 6, 2008
Population-based phase I trial of irinotecan and epirubicinDerick Lau, Jewel Johl, Minh Huynh, et al.Cancers|September 9, 2022
Prevalence of <i>ARID1A</i> Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-AlterationsRazelle Kurzrock, Charu Aggarwal, Caroline Weipert, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509Elizabeth M Blanchard, James Moon, Paul J Hesketh, et al.JCO Precision Oncology|June 17, 2025
Costs and Benefits of Whole-Exome, Whole-Transcriptome Sequencing in Patients With Advanced Non-Small Cell Lung CancerJesse D Ortendahl, Gebra Cuyun Carter, Snehal G Thakkar, et al.Investigational New Drugs|October 22, 2011
Feasibility study of intra-patient sorafenib dose-escalation or re-escalation in patients with previously treated advanced solid tumorsThomas J Semrad, Courtney Eddings, Chong-Xian Pan, et al.Frontiers in Oncology|March 13, 2026
Composite patient-reported outcomes and risk prediction for overall survival in advanced non-small cell lung cancer with first-line cemiplimabDavid Gandara, Miranda Gogishvili, Ahmet Sezer, et al.Pageof 8